U.S. REITS Stock News

NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Assessing Payoneer Global (PAYO) After Steep Share Price Declines

If you are wondering whether Payoneer Global's share price offers good value right now, you are not alone. This article focuses squarely on what the current market price might be implying. Payoneer Global's share price closed at US$4.43, with returns of an 8.7% decline over 7 days, a 26.2% decline over 30 days, an 18.6% decline year to date, a 37.6% decline over 1 year, a 27.7% decline over 3 years and a 60.2% decline over 5 years. Recent coverage around Payoneer Global has focused on its...
NasdaqGS:ROST
NasdaqGS:ROSTSpecialty Retail

Is It Too Late To Consider Ross Stores (ROST) After A 72% One-Year Surge?

If you are wondering whether Ross Stores is still reasonably priced after its strong run, this article will walk through what the current share price might imply about value. The stock recently closed at US$209.84, with returns of 9.1% over the last 30 days and 72.4% over the past year. The 7-day return of a 2.3% decline shows that shorter term sentiment can look quite different to the longer trend. Recent coverage of Ross Stores has focused on its role as a large off price retailer and how...
NYSE:CRC
NYSE:CRCOil and Gas

Is It Time To Reassess California Resources (CRC) After Its Recent Share Price Swings?

If you are looking at California Resources and wondering whether the current share price reflects its true worth, you are not alone. The stock closed at US$61.47 recently, after a 5.1% decline over the last 7 days, an 8.3% gain over 30 days, and returns of 32.5% year to date and 45.6% over the last year. These moves have come as investors continue to track company specific developments and broader energy sector sentiment, with recent attention on how producers are positioning themselves...
NasdaqGS:MRTN
NasdaqGS:MRTNTransportation

Assessing Marten Transport (MRTN) Valuation After Recent Share Price Weakness

What Marten Transport’s recent performance might mean for investors Marten Transport (MRTN) has come onto investors’ radar after a period where the share price showed a 2.5% gain over the past day, in contrast with negative moves over the past week and month. See our latest analysis for Marten Transport. That 2.5% one day share price gain comes after a 14.2% 30 day share price decline and a 12.5% 1 year total shareholder return loss, which suggests recent momentum has been fading rather than...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

SLM’s Accelerated Buyback And Tech Hire Put Valuation In New Focus

SLM Corporation (NasdaqGS:SLM) has entered into a $200 million accelerated share repurchase agreement under its existing $500 million share repurchase authorization. The ASR is structured to reduce the company’s share count more quickly than open market buybacks. SLM has also appointed Steve Turner as Chief Technology and Enablement Officer, adding new leadership focused on technology efforts. SLM is a major player in education financing and related services, operating in a sector that...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Veeva Systems Buys Ostro As AI Deal Undervalues Share Price

Veeva Systems (NYSE:VEEV) has acquired Ostro, a life sciences brand engagement platform that uses advanced AI for compliant communications with patients and doctors. The deal adds AI driven conversational capabilities to Veeva’s commercial offering for pharmaceutical and biotech customers. Ostro focuses on compliant, personalized engagement for healthcare professionals and patients across digital channels. Veeva Systems enters this deal with a share price of $178.88 and a mixed return...
NYSE:SEI
NYSE:SEIEnergy Services

Assessing Solaris Energy Infrastructure (SEI) Valuation After Its Shift Toward Power And Data Center Customers

Why Solaris Energy Infrastructure is on investors’ radar Solaris Energy Infrastructure (SEI) has been drawing fresh attention after its recent rebrand from Solaris Oilfield Infrastructure, with investors reassessing how the business now spans both power solutions and logistics for energy and data center customers. See our latest analysis for Solaris Energy Infrastructure. While the share price has eased 2.5% over the last day and is down 3.2% over the past month, a 12.9% 90 day share price...
NYSE:AMRC
NYSE:AMRCConstruction

Is It Time To Reassess Ameresco (AMRC) After Its Recent Share Price Pullback?

If you are wondering whether Ameresco's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. Ameresco's stock has pulled back recently, with returns of a 3.9% decline over 7 days, a 26.7% decline over 30 days and a 19.4% decline year to date, even though the 1-year return sits at 134.4%, while 3-year and 5-year returns are a 42.7% decline and a 43.9% decline respectively. Recent news coverage around...
NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Assessing Navan (NAVN) Valuation After Recent Share Price Weakness And AI Growth Expectations

Navan (NAVN) has been drawing attention after a sharp pullback, with the stock down about 20% over the past month and close to 39% over the past 3 months. See our latest analysis for Navan. The recent weakness, including a 7.69% 1 day share price return and a 45.35% year to date share price return, suggests momentum has been fading despite interest in Navan's AI powered travel and expense platform and its latest close at $8.88. If sharp moves in a single name feel uncomfortable, you can...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Valuation Check After Sharp Multi‑Month Share Price Rebound

Moderna (MRNA) has been back on many investors’ screens after a sharp move in recent months, with the stock up about 30% over the past month and roughly 78% in the past 3 months. See our latest analysis for Moderna. While the share price has eased slightly over the last day, Moderna’s recent 30-day share price return of about 30% and year to date gain of roughly 70% point to building momentum, even as the 3 and 5 year total shareholder returns remain deeply negative. If Moderna’s recent...
NYSE:NVST
NYSE:NVSTMedical Equipment

Has Envista Holdings (NVST) Pulled Back Too Far After Recent Share Price Weakness?

If you are wondering whether Envista Holdings is attractively priced right now, this article will walk through what the current share price might be implying about its value. The stock last closed at US$25.44, with a 56.6% return over the past year, a 17.3% gain year to date, but declines of 8.9% over 7 days and 15.7% over 30 days that may have shifted how investors think about its risk and reward. Recent news flow around Envista has focused on its position in the healthcare space and how...
NYSE:AAP
NYSE:AAPSpecialty Retail

A Look At Advance Auto Parts (AAP) Valuation As Turnaround Progress Restores Profitability

Advance Auto Parts (AAP) is back on investors’ radar after management reported a return to positive comparable sales and operating income profitability, following extensive turnaround work across its supply chain, merchandising, and store operations. See our latest analysis for Advance Auto Parts. The recent turnaround update and conference commentary come after a volatile few years. The share price is at US$52.66 with a 90 day share price return of 13.56% and a 1 year total shareholder...
NasdaqGM:HLMN
NasdaqGM:HLMNMachinery

How Investors Are Reacting To Hillman Solutions (HLMN) Earnings Miss And Cautious Full-Year Outlook

Hillman Solutions recently reported a softer quarter, with revenue growing 4.5% year on year but falling short of analyst expectations and issuing full-year revenue guidance that also trailed consensus. Despite lifting its full-year outlook more than peers, Hillman’s results were viewed unfavorably, highlighting how even incremental misses against expectations can weigh on sentiment around its professional tools and hardware business. Next, we’ll examine how this earnings miss and cautious...
NasdaqGS:IRDM
NasdaqGS:IRDMTelecom

Does Iridium (IRDM) Dividend Stability Reflect Strategic Confidence or Limited Reinvestment Ambition?

Iridium Communications Inc. has affirmed a quarterly dividend of US$0.1500 per share, payable on March 31, 2026, to shareholders of record and ex-dividend on March 16, 2026. This dividend affirmation, following a quarter where earnings per share exceeded analyst expectations despite flat revenue, underscores management’s commitment to ongoing cash returns. We’ll now examine how the sustained dividend alongside better-than-expected earnings shapes Iridium’s investment narrative and future...
NYSE:IR
NYSE:IRMachinery

Assessing Ingersoll Rand (IR) Valuation After Recent Share Price Weakness

What recent performance says about Ingersoll Rand (IR) Ingersoll Rand (IR) has recently seen mixed share performance, with a 4.7% decline over the past day, a 10.3% decline over the past week, and a 17.0% decline over the past month. Even with that pressure, the stock shows a small 0.7% decline over the past 3 months. Longer windows are positive, including a 1.8% total return over the past year and higher multi year returns. See our latest analysis for Ingersoll Rand. Recent selling pressure...
NYSE:IONQ
NYSE:IONQTech

IonQ Links RoNaQCI Deployment With SkyWater Deal And Security Focus

IonQ (NYSE:IONQ) is providing quantum key distribution technology for Romania’s National Quantum Communication Infrastructure, RoNaQCI, aimed at securing critical European communications. The company announced a US$1.8b acquisition of SkyWater Technology, creating what it describes as the industry's first vertically integrated quantum company. These developments expand IonQ’s role in European secure communications and bring chip manufacturing capabilities in house. IonQ, a pure play quantum...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Assessing Micron Technology (MU) Valuation As AI Memory Demand And Partnerships Drive A Strong Cycle

Micron Technology (MU) is back in focus after Applied Materials announced a collaboration to co develop next generation DRAM, high bandwidth memory and NAND, aimed at more energy efficient AI systems. See our latest analysis for Micron Technology. Despite a 3.2% one day share price decline to US$405.35 during a broader tech pullback, Micron’s recent news flow around AI memory partnerships, product launches, and capacity expansions lines up with strong momentum, reflected in an 8.6% 30 day...
NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

Could AIRO Group Holdings' Drone Focus and Vertical Integration Redefine Its Defense Narrative (AIRO)?

On March 11, 2026, AIRO Group Holdings, Inc. presented at the Cantor Global Technology & Industrial Growth Conference in New York, with Executive Chairman Chirinjeev Kathuria, CEO Joe Burns, and CFO Mariya Pylypiv outlining the company’s integrated aerospace and defense offering. The focus on defense-oriented drones, proprietary technology and vertically integrated manufacturing, together with R&D and government certifications, underscored AIRO’s effort to build recurring revenue across...
NasdaqGS:ICUI
NasdaqGS:ICUIMedical Equipment

ICU Medical Confronts Revenue Strain As Valuation Signals Potential Upside

ICU Medical, NasdaqGS:ICUI, is dealing with ongoing revenue stagnation and rising capital intensity that point to operational and market pressures. Future sales are projected to decline, alongside shrinking free cash flow margins, highlighting concerns about the company’s ability to convert revenue into cash. These developments are emerging as fresh issues for investors and other stakeholders who follow ICU Medical’s financial and competitive position. ICU Medical’s current share price of...
NYSE:CL
NYSE:CLHousehold Products

Colgate-Palmolive Adds Healthcare CEO To Board And Extends Dividend Streak

Colgate-Palmolive (NYSE:CL) appointed Christopher Boerner, CEO of Bristol-Myers Squibb, to its Board of Directors. Board member Steven Cahillane will not stand for reelection at the company’s upcoming annual meeting. The company also announced its 62nd consecutive annual dividend increase. Colgate-Palmolive, the global consumer products company behind oral care, personal care, and home care brands, is adding a senior healthcare executive to its board at a time when cross-industry expertise...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Is It Time To Reassess Akamai Technologies (AKAM) After Its Strong Share Price Run?

If you are wondering whether Akamai Technologies is fairly priced or if the recent buzz has left it mispriced, you are in the right place for a closer look at what the current share price might be implying. Akamai's share price closed at US$105.47, with returns of 4.4% over 7 days, 11.7% over 30 days, 23.9% year to date, 34.1% over 1 year and 45.4% over 3 years, while the 5 year return stands at 7.4%. These price moves sit against an ongoing focus on Akamai's role in content delivery and...
NYSE:USFD
NYSE:USFDConsumer Retailing

Is It Too Late To Consider US Foods Holding (USFD) After Its Strong Multi Year Rally?

If you have been wondering whether US Foods Holding is still reasonably priced after its recent run, this article walks through what the numbers actually say about its current value. The stock last closed at US$92.61, with returns of 0.5% over 7 days, 2.1% over 30 days, 24.1% year to date and 45.4% over the past year, while the 3 year and 5 year returns sit at 167.8% and 151.3% respectively. Recent attention on US Foods has been driven by ongoing interest in large foodservice distributors...
NasdaqGS:CRVL
NasdaqGS:CRVLHealthcare

Is CorVel’s (CRVL) Debt-Free Strength a Hidden Edge in Claims Management or Just Prudence?

Recent analysis highlighted that CorVel passed a high-quality investment screen, underpinned by very large returns on invested capital and a debt-free balance sheet in its cost containment and claims management business. This focus on financial strength and operational resilience has drawn attention from investors who prioritize durable business models and conservative balance sheets. Next, we’ll examine how CorVel’s debt-free position shapes its investment narrative in light of the latest...
NYSE:MRK
NYSE:MRKPharmaceuticals

A Look At Merck (MRK) Valuation As Recent Gains Contrast Conflicting Fair Value Estimates

Merck (MRK) is back on investors’ radar after recent trading left the shares around $115.91, with short term returns mixed, while the past 3 months and year have shown stronger overall performance metrics. See our latest analysis for Merck. Short term share price returns for Merck have been soft, but a 15.56% 90 day share price return and 26.99% 1 year total shareholder return suggest momentum has recently been building for long term holders. If Merck’s moves have you reassessing healthcare,...